The Gabelli Healthcare & Wellness Trust of (GRX) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-03, The Gabelli Healthcare & Wellness Trust of (NYSE: GRX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $10.20 (+0.69% 1D, market cap $173.2M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 13/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 9/20. Across 1097 tracked Financials issuers, GRX ranks #513 in composite RQD confidence.
Within the Financials sector (Finance/Investors Services), GRX carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, SCM (Stellus Capital Investment Corporation) holds a E grade (32/100 RQD, P/E 7.4x, ROIC 7.3%, cap $199.4M) and GNT (GAMCO Natural Resources Gold & Income Trust) posts a D grade (46/100 RQD, P/E N/A, ROIC —, cap $149.8M). Among the 5-stock peer group, SCM leads on earnings multiple (7.4x) while SCM leads on capital efficiency (7.3% ROIC).
For The Gabelli Healthcare & Wellness Trust of (GRX), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity and sector rank #513 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±2.5% realized swing band)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment
Even with a 56/100 (D+) score, GRX faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Company executives have done more routine share selling than personal cash buying lately.
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($9.83) or 200D SMA ($9.52) invalidates the momentum regime and cuts Target Base ($10.11) toward Bear Floor ($7.89).
The Gabelli Healthcare & Wellness Trust of (GRX) advanced +0.69% to $10.20, trading at 98% of its 52-week range ($8.8 – $10.23). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
Stock Traders Daily report covering The Gabelli Healthcare & Wellness Trust of (GRX) market action, institutional positioning, and fundamental catalysts.
RYE, N.Y., Aug. 12, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution payable September 23, 2026 to common sh
RYE, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution payable on June 23, 2026 to common share
Income investors shopping the healthcare aisle often land on Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), a closed-end fund managed by Gabelli Funds that has quietly paid quarterly distributions for more than 14 con
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) has quietly maintained a quarterly dividend for over a decade, and a recent increase has drawn fresh attention from income-focused investors. The question is whether that
RYE, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution payable on March 24, 2026 to common sha
Under Armour, W.R. Berkley, and Gabelli Healthcare & WellnessRx Trust have seen some huge insider purchases, and there were some other notable insider purchases as well.
RYE, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution which will be payable on December 19, 2
In the past week or so, renowned investors Carl Icahn and Mario Gabelli led some huge insider buying. These were not the only notable purchases though.
<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE1QcWlpMFdqLW9vblJEU211NVZnSlVnZGE2ejJxaDBhV3MtMm5YaE9XcmV4TzFOWUQxOUdkb2NZZXgzMHBxSmlPRWp1M3lwcEpwUGpLak5HdEFiU0dqLXBuTUhhbEl0NE9iYUxmdGVmN0tZT29y?oc=5" targ
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on GRX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for GRX. Explore sector supply chains on /butterfly.
Across 1097 tracked Financials securities in the Roarable RQD universe, The Gabelli Healthcare & Wellness Trust of (GRX) ranks #513 by composite RQD confidence (56/100, grade D+) and #910 by equity capitalization ($173.2M). Within this direct 5-issuer industry benchmark cohort, SCM leads on earnings valuation at 7.4x trailing P/E, while SCM leads on capital efficiency and profitability with 7.3% ROIC and — gross margin. GRX currently leads its immediate peer cohort in composite quantitative strength at 56/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| GRX
ACTIVE
The Gabelli Healthcare & Wellness Trust of | D+ | 56/100 | — | — | — | +0.69% | $173.2M | Benchmark Subject |
| SCM Stellus Capital Investment Corporation | E | 32/100 | 7.4x | — | 7.3% | +2.57% | $199.4M | /scm-vs-grx → |
| GNT GAMCO Natural Resources Gold & Income Trust | D | 46/100 | — | — | — | -0.62% | $149.8M | /gnt-vs-grx → |
| FTF Franklin Limited Duration Income Trust of | D | 44/100 | — | — | — | +0.37% | $219.4M | /ftf-vs-grx → |
| ACV Virtus Diversified Income & Convertible Fund of | D- | 41/100 | — | — | — | -1.51% | $247.3M | /acv-vs-grx → |
The Gabelli Healthcare & Wellness Trust of (GRX) operates in Finance/Investors Services (Financials) with an equity capitalization of $173.2M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.
As of 2026-11-03, The Gabelli Healthcare & Wellness Trust of (NYSE: GRX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $10.20 (+0.69% 1D, market cap $173.2M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 13/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 9/20. Across 1097 tracked Financials issuers, GRX ranks #513 in composite RQD confidence.
Within the Financials sector (Finance/Investors Services), GRX carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, SCM (Stellus Capital Investment Corporation) holds a E grade (32/100 RQD, P/E 7.4x, ROIC 7.3%, cap $199.4M) and GNT (GAMCO Natural Resources Gold & Income Trust) posts a D grade (46/100 RQD, P/E N/A, ROIC —, cap $149.8M). Among the 5-stock peer group, SCM leads on earnings multiple (7.4x) while SCM leads on capital efficiency (7.3% ROIC).
For The Gabelli Healthcare & Wellness Trust of (GRX), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity and sector rank #513 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
GRX last traded at $10.20 (+0.69% on volume of 24,229 shares), positioning the stock +3.76% above its 50-day simple moving average ($9.83) and +7.14% above its 200-day simple moving average ($9.52). Across its 52-week range of $8.80 to $10.23, GRX sits at the 97.9% percentile with a 14-day RSI of 66.3 (BULLISH MOMENTUM) and an implied next-earnings move of ±2.5% ($9.94 to $10.46).
The Gabelli Healthcare & Wellness Trust of (GRX) earns a live Roarable RQD composite score of 56/100, corresponding to a D+ letter grade (Roarable Sell) at a spot price of $10.20 (+0.69% 1D, market capitalization $173.2M).
. The source describes the company as The Gabelli Healthcare & Wellness Trust of, with a market capitalization of $0.2B.
The supply chain is recorded as "NONE," with an empty list of butterfly links and no proprietary signals. The sector is Financials and the industry is Finance/Investors Services; no further linkage is provided.
Real-time company headlines, analyst actions, and sector developments for The Gabelli Healthcare & Wellness Trust of (GRX) • Click "Debate This Headline" to argue it in the Roar Pit below
Stock Traders Daily report covering The Gabelli Healthcare & Wellness Trust of (GRX) market action, institutional positioning, and fundamental catalysts.
RYE, N.Y., Aug. 12, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution payable September 23, 2026 to common sh
RYE, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution payable on June 23, 2026 to common share
Income investors shopping the healthcare aisle often land on Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), a closed-end fund managed by Gabelli Funds that has quietly paid quarterly distributions for more than 14 con
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) has quietly maintained a quarterly dividend for over a decade, and a recent increase has drawn fresh attention from income-focused investors. The question is whether that
RYE, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution payable on March 24, 2026 to common sha
Under Armour, W.R. Berkley, and Gabelli Healthcare & WellnessRx Trust have seen some huge insider purchases, and there were some other notable insider purchases as well.
RYE, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution which will be payable on December 19, 2
The street is overcomplicating The Gabelli Healthcare & Wellness Trust of (GRX). Institutional positioning scores 13 of 20 in the RQD model, the strongest pillar relative to its maximum.. With an RQD score of 56/100 (D+) and Forensic Balance Sheet at 13/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $10.94.
Both sides have a point here — GRX's 13/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.
ROIC and FCF yield are both recorded at 0%, anchoring the cash-engine pillar at 11 of 20.. Look at the math on GRX: paying current EV/EBITDA multiples for 0.0% ROIC and 0.0% operating margins leaves zero margin of safety if Finance/Investors Services demand softens. I'd wait for a retest of $8.91 before getting long.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Gideon Ashmere, Ellis Vennor, Tessa Rookmere, Soren Halewick, Iona Brackenford, Nadia Vellacrest, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your email address below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).